2021
The effect of short radiation treatment breaks on chemo‐radiotherapy for oropharyngeal cancers
Rybkin A, Kang JJ, Lee A, Kitpanit S, Fan M, Mohamed N, Cartano O, Zakeri K, Gelblum D, Sherman E, Dunn L, Boyle J, Wong R, Chen L, Yu Y, McBride SM, Tsai CJ, Riaz N, Lee NY. The effect of short radiation treatment breaks on chemo‐radiotherapy for oropharyngeal cancers. Head & Neck 2021, 43: 3796-3809. PMID: 34585792, PMCID: PMC9414892, DOI: 10.1002/hed.26879.Peer-Reviewed Original ResearchConceptsRadiation treatment breaksOropharyngeal squamous cell carcinomaOverall treatment timeTreatment breaksClinical outcomesDefinitive concurrent chemoradiotherapySquamous cell carcinomaConcurrent chemoradiotherapyOPSCC patientsOropharyngeal cancerDisease failureCell carcinomaNeck cancerCancer recurrenceConsecutive cohortMultivariate analysisSignificant associationPatientsCancerFurther investigationProlongationDaysOutcomesNumerous studiesChemoradiotherapy
2020
Profiling the Spatial Composition of the Hypoxic Tumor-Immune Microenvironment through Multiplex Immunohistochemistry in a Prospective cohort of HPV Associated Oropharynx Cancer
Chen L, Hollmann T, Li Y, Katabi N, Shah R, Yu Y, Kang J, Tsai C, McBride S, Lee N, Riaz N. Profiling the Spatial Composition of the Hypoxic Tumor-Immune Microenvironment through Multiplex Immunohistochemistry in a Prospective cohort of HPV Associated Oropharynx Cancer. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1133. DOI: 10.1016/j.ijrobp.2019.11.363.Peer-Reviewed Original ResearchPredictors of Immunotherapy Response in Head and Neck Cancer: Per Lesion Analysis of a Prospective Randomized Trial with Nivolumab
Yu Y, Chen L, Riaz N, Tsai C, Kang J, Sherman E, Lee N, McBride S. Predictors of Immunotherapy Response in Head and Neck Cancer: Per Lesion Analysis of a Prospective Randomized Trial with Nivolumab. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1131. DOI: 10.1016/j.ijrobp.2019.11.359.Peer-Reviewed Original Research
2019
Predictors of Early Response to Immunotherapy in Head and Neck Cancer: A Secondary Clinical and Radiomic Analysis of a Prospective Randomized Trial with Nivolumab
Yu Y, Chen L, Riaz N, Kang J, Thor M, Veeraraghavan H, Apte A, Tsai C, Deasy J, Sherman E, Lee N, McBride S. Predictors of Early Response to Immunotherapy in Head and Neck Cancer: A Secondary Clinical and Radiomic Analysis of a Prospective Randomized Trial with Nivolumab. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s211. DOI: 10.1016/j.ijrobp.2019.06.286.Peer-Reviewed Original Research